A detailed history of Diversified Trust CO transactions in Incyte Corp stock. As of the latest transaction made, Diversified Trust CO holds 45,191 shares of INCY stock, worth $3.18 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
45,191
Previous 52,398 13.75%
Holding current value
$3.18 Million
Previous $3.18 Million 5.95%
% of portfolio
0.09%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$57.33 - $68.61 $413,177 - $494,472
-7,207 Reduced 13.75%
45,191 $2.99 Million
Q2 2024

Jul 16, 2024

BUY
$51.18 - $63.75 $836,076 - $1.04 Million
16,336 Added 45.3%
52,398 $3.18 Million
Q1 2024

Apr 18, 2024

BUY
$56.55 - $66.59 $1.13 Million - $1.33 Million
19,944 Added 123.74%
36,062 $2.05 Million
Q4 2023

Jan 08, 2024

BUY
$52.16 - $64.19 $158,253 - $194,752
3,034 Added 23.19%
16,118 $1.01 Million
Q3 2023

Nov 17, 2023

BUY
$57.77 - $65.93 $286,654 - $327,144
4,962 Added 61.09%
13,084 $755,000
Q2 2023

Jul 18, 2023

SELL
$60.95 - $75.51 $27,854 - $34,508
-457 Reduced 5.33%
8,122 $505,000
Q1 2023

Apr 07, 2023

BUY
$70.23 - $86.01 $257,814 - $315,742
3,671 Added 74.8%
8,579 $620,000
Q4 2022

Jan 17, 2023

SELL
$67.18 - $84.11 $135,166 - $169,229
-2,012 Reduced 29.08%
4,908 $394,000
Q3 2022

Oct 14, 2022

BUY
$66.18 - $82.86 $105,358 - $131,913
1,592 Added 29.88%
6,920 $461,000
Q2 2022

Jul 12, 2022

SELL
$66.18 - $83.18 $26,141 - $32,856
-395 Reduced 6.9%
5,328 $405,000
Q1 2022

Apr 07, 2022

BUY
$66.02 - $79.71 $185,846 - $224,383
2,815 Added 96.8%
5,723 $455,000
Q4 2021

Jan 13, 2022

BUY
$63.34 - $74.11 $184,192 - $215,511
2,908 New
2,908 $213,000
Q1 2020

Apr 10, 2020

SELL
$63.18 - $85.97 $187,581 - $255,244
-2,969 Closed
0 $0
Q4 2019

Jan 09, 2020

BUY
$73.04 - $95.72 $216,855 - $284,192
2,969 New
2,969 $259,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.